title: Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score.
abstract: OBJECTIVE
  To determine predictors of intensive care unit (ICU) mortality in patients with community-acquired pneumonia (CAP), to develop a pneumonia-specific prognostic index, and to evaluate this index prospectively.
  
  
  METHODS
  Combined retrospective and prospective clinical study over two periods: January 1987-December 1992 and January 1993-December 1994.
  
  
  METHODS
  Four medical ICUs in the north of France.
  
  
  METHODS
  Derivation cohort: 335 patients admitted to one ICU were retrospectively studied to determine prognosis factors and to develop a pneumonia-specific prognostic index. Validation cohort: 125 consecutive patients, admitted to four ICUs, were prospectively enrolled to evaluate this index.
  
  
  RESULTS
  In the derivation cohort, 16 predictors of mortality were identified and assigned a value directly proportional to their magnitude in the mortality model: aspiration pneumonia (-0.37), grading of sepsis > or = 11 (-0.2), antimicrobial combination (-0.01), Glasgow score > 12+mechanical ventilation (MV) (+0.09), serum creatinine > or = 15 mg/l (+0.22), chest involvement shown by X-ray > or = 3 lobes (+0.28), shock (+0.29), bacteremia (+0.29), initial MV (+0.29), underlying ultimately or rapidly fatal illness (+0.31), Simplified Acute Physiology Score > or = 12 (+0.49), neutrophil count < or = 3500/ mm3 (+0.52), acute organ system failure score > or = 2 (+0.64), delayed MV (+0.67), immunosuppression (+1.38), and ineffective initial antimicrobial therapy (+1.5). An index was obtained by adding each patient's points. According to a receiver operating characteristic curve, the cut-off value of this index was 2.5. In the validation cohort, an index of > or = 2.5 could predict death with a positive predictive value of 0.92, sensitivity 0.61, and specificity 0.98.
  
  
  CONCLUSIONS
  This index, which performs well in classifying patients at high-risk of death, may help physicians in initial patient care (appropriateness of the initial antimicrobial therapy) and guide future clinical research (analysis and design of therapeutic trials).
authors.affiliation: Service de Réanimation Médicale et Maladies Infectieuses, Centre Hospitalier, Tourcoing, France.
authors.forename: O
authors.initials: O
authors.lastname: Leroy
authors.forename: H
authors.initials: H
authors.lastname: Georges
authors.forename: C
authors.initials: C
authors.lastname: Beuscart
authors.forename: B
authors.initials: B
authors.lastname: Guery
authors.forename: C
authors.initials: C
authors.lastname: Coffinier
authors.forename: C
authors.initials: C
authors.lastname: Vandenbussche
authors.forename: D
authors.initials: D
authors.lastname: Thevenin
authors.forename: G
authors.initials: G
authors.lastname: Beaucaire
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017714:Community-Acquired Infections / Q000145:classification* / Q000401:mortality; D003422:Critical Care; D016002:Discriminant Analysis; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000145:classification* / Q000401:mortality; D011379:Prognosis; D011446:Prospective Studies; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index